The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Berns S.A.

National Medical Research Center for Therapy and Preventive Medicine

Panfilova A.A.

City Clinical Hospital named after F.I. Inozemtsev

Salichova S.I.

City Clinical Hospital named after F.I. Inozemtsev

Zernova E.V.

City Clinical Hospital named after F.I. Inozemtsev

Chadorich M.A.

Russian University of Medicine

Tavlueva E.V.

National Medical Research Center for therapy and Preventive Medicine;
City Clinical Hospital named after F.I. Inozemtsev

Neurological complications in patients underwent COVID-19

Authors:

Berns S.A., Panfilova A.A., Salichova S.I., Zernova E.V., Chadorich M.A., Tavlueva E.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2024;27(6): 98‑104

DOI: 10.17116/profmed20242706198

Read: 1757 times

Download PDF (RU)
Contact the author
Table of contents

NEUROLOGICAL COMPLICATIONS IN PATIENTS UNDERWENT COVID-19
NEUROLOGICAL COMPLICATIONS IN PATIENTS UNDERWENT COVID-19

To cite this article:

Berns SA, Panfilova AA, Salichova SI, Zernova EV, Chadorich MA, Tavlueva EV. Neurological complications in patients underwent COVID-19. Russian Journal of Preventive Medicine. 2024;27(6):98‑104. (In Russ.)
https://doi.org/10.17116/profmed20242706198

 
Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Morphofunctional and biochemical dete­rminants of endo­thelial function in patients with a new coro­navirus infe­ction COVID-19. Russian Journal of Preventive Medi­cine. 2024;(10):90-96
Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data). Russian Journal of Preventive Medi­cine. 2024;(12):114-121
ALDH1, CD133, CD34-positive cancer stem cells in lung adenocarcinoma in patients who had a new coro­navirus infe­ction and retained the persistence of viral proteins in the lung tissue. Russian Journal of Archive of Pathology. 2024;(5):5-14
Factors affe­cting the quality of life of patients with neurological mani­festations of post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):44-50
«Cytokine storm» as an immu­nopathologic reaction in pregnant women in the first trimester. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):19-24
Inci­dence of sudden cardiac death among diseases of the circulatory system during the COVID-19 pandemic in the Penza region. Fore­nsic Medi­cal Expe­rtise. 2024;(5):10-14
Labo­ratory tests for diagnostics of cell immu­nity against SARS-CoV-2 (review of lite­rature). Labo­ratory Service. 2024;(3):31-36
Loca­lization features of FAP-positive acti­vated stro­mal cells in fibrosis in patients with new coro­navirus infe­ction COVID-19. Russian Journal of Archive of Pathology. 2024;(6):5-14
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Lapa­roscopic appe­ndectomy for appe­ndiceal muco­cele in a patient with COVID-19. Endo­scopic Surgery. 2024;(6):41-45
Abstract:

Despite the fact that COronaVIrus Disease 2019 (COVID-19) primarily affects the respiratory system, it is known that many so-called post-COVID patients, who have no symptoms of acute infectious process, have long-term physiological, psychological and cognitive disorders. The most common complications are neurological. The article considers pathogenetic variants of affect with the Severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) of the central and peripheral nervous system, as well as neurological clinical manifestations in both acute and long-term periods of COVID-19. The analysis of literature data for the period of the pandemic from 2020 to 2023 was conducted.

Keywords:

COVID-19
SARS-CoV-2
neurological complications

Authors:

Berns S.A.

National Medical Research Center for Therapy and Preventive Medicine

Panfilova A.A.

City Clinical Hospital named after F.I. Inozemtsev

Salichova S.I.

City Clinical Hospital named after F.I. Inozemtsev

Zernova E.V.

City Clinical Hospital named after F.I. Inozemtsev

Chadorich M.A.

Russian University of Medicine

Tavlueva E.V.

National Medical Research Center for therapy and Preventive Medicine;
City Clinical Hospital named after F.I. Inozemtsev

Received:

26.04.2024

Accepted:

19.05.2024

Close metadata

References:

  1. Kamchatnov PR, Solov'eva EYu, Khasanova DR, et al. Asthenic and cognitive disorders in patients having had COVID-19. RMZh. Medicinskoe obozrenie. 2021;5(10):636-641. (In Russ.). https://doi.org/10.32364/2587-6821-2021-5-10-636-641
  2. Dai X, Cao X, Jiang Q, et al. Neurological complications of COVID-19. QJM: Monthly Journal of the Association of Physicians. 2023;116(3):161-180.  https://doi.org/10.1093/qjmed/hcac272
  3. Leng A, Shah M, Ahmad SA, et al. Affiliations expand Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells. 2023;12(5):816  https://doi.org/10.3390/cells12050816
  4. Alabsi H, Emerson K, Lin DJ. Neurorecovery after Critical COVID-19 Illness. Seminars in Neurology. 2023;43(2):312-320.  https://doi.org/10.1055/s-0043-1768714
  5. Huang J, Zheng M, Tang X, et al. Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience. Frontiers In Neurology. 2020;11:659.  https://doi.org/10.3389/fneur.2020.00659
  6. Jackson CB, Farzan M, Chen B, et al. Mechanisms of SARS-CoV-2 entry into cells. Nature Reviews. Molecular Cell Biology. 2022;23(1):3-20.  https://doi.org/10.1038/s41580-021-00418-x
  7. Karnik M, Beeraka NM, Uthaiah CA, et al. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development. Molecular Neurobiology. 2021; 58(9):4535-4563. https://doi.org/10.1007/s12035-021-02399-6
  8. Mehrabani MM, Karvandi MS, Maafi P, et al. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Reviews in Medical Virology. 2022;32(6):e2334. https://doi.org/10.1002/rmv.2334
  9. Pepe A, Pietropaoli PS, Vos M, et al. Barba-Spaeth G, Zurzolo C. Tunneling nanotubes provide a route for SARS-CoV-2 spreading. Science Advances. 2022;8(29):eabo0171. https://doi.org/10.1126/sciadv.abo0171
  10. Bayat AH, Azimi H, Moghaddam MH, et al. COVID-19 causes neuronal degeneration and reduces neurogenesis in human hippocampus. Apoptosis. 2022;27(11-12):852-868.  https://doi.org/10.1007/s10495-022-01754-9
  11. Zanza C, Romenskaya T, Manetti AC, et al. Cytokine Storm in COVID-19: Immunopathogenesis and Therapy. Medicina (Kaunas, Lithuania). 2022; 58:144.  https://doi.org/10.3390/medicina58020144
  12. Hingorani KS, Bhadola S, Cervantes-Arslanian AM. COVID-19 and the brain. Trends in Cardiovascular Medicine. 2022;32(6):323-330.  https://doi.org/10.1016/j.tcm.2022.04.004
  13. Gill C, Tracey A, Cho TA. Neurologic Complications of COVID-19. Continuum (Minneapolis, Minn.). 2023;29(3):946-965.  https://doi.org/10.1212/CON.0000000000001272
  14. Alkodaymi MS, Omrani OA, Fawzy NA, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clinical Microbiology and Infection. 2022;28(5): 657-666.  https://doi.org/10.1016/j.cmi.2022.01.014
  15. Alekseenko YuV. Cognitive Impairment after COVID-19. Recept. 2022;25(4): 496-502. (In Russ.). https://doi.org/10.34883/PI.2022.25.4.009
  16. Zakharov DV, Buriak YV. The Post-COVID-19 cognitive impairment. A modern view of the problem, pathogenesis and treatment. Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Behtereva. 2021;55(4):97-105. (In Russ.). https://doi.org/10.31363/2313-7053-2021-57-4-97-105
  17. Kabysh SS, Karpenkova AD, Prokopenko SV. Cognitive impairments and COVID-19. Sibirskoe medicinskoe obozrenie. 2022;2:40-48. (In Russ.). https://doi.org/10.20333/25000136-2022-2-40-48
  18. Zhitkova YuV, Khasanova DR. Treatment experience of post-COVID cognitive impairment (clinical observation). Meditsinskiy sovet. 2022;(11):102-107. (In Russ.). https://doi.org/10.21518/2079-701X-2022-16-11-102-107
  19. Lazebnik LB, Tarasova LV, Komarova EA, et al. Change in concentration of ammonia and other biochemical indicators in patients with new coronaviral infection. Jeksperimental‘naja i klinicheskaja gastrojenterologija. 2021;188(4): 76-83. (In Russ.). https://doi.org/10.31146/1682-8658-ecg-188-4-76-83
  20. Plotnikova EYu, Sinkova MN, Isakov LK. Asthenia and fatigue in hyperammonemia: etiopathogenesis and methods of correction. Meditsinskiy sovet. 2021;(21-1):95-104. (In Russ.). https://doi.org/10.21518/2079-701X-2021-21-1-95-104
  21. Podymova SD. New approaches to the pathogenesis, clinic, and treatment of hepatic encephalopathy. Terapevticheskii arkhiv. 2021;93(2):236-242. (In Russ.). https://doi.org/10.26442/00403660.2021.02.200613
  22. Bohlken J, Weber K, Heller SR, et al. Mild Cognitive Disorder in Post-COVID-19 Syndrome: A Retrospective Cohort Study of 67,000 Primary Care Post-COVID Patients. Journal of Alzheimer’s Disease Reports. 2022;6(1): 297-305. 
  23. Sekendiz Z, Clouston SAP, Morozova O, et al. Assessment and characterization of COVID-19 related cognitive decline: results from a natural experiment. MedRxiv. 2023:2023.11.06.23298101. https://doi.org/10.1101/2023.11.06.23298101
  24. Almeria M, Cejudo JC, Sotoca J, et al. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain, Behavior, and Immunity — Health. 2020;(9):100163. https://doi.org/10.1016/j.bbih.2020.100163
  25. Crook H, Ramirez A, Hosseini A, et al. European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19. Brain Connectivity. 2023;13(4): 178-210.  https://doi.org/10.1089/brain.2022.0058
  26. Liguori C, Pierantozzi M, Spanetta M, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain, Behavior, and Immunity. 2020;88:11-16.  https://doi.org/10.1016/j.bbi.2020.05.037
  27. Alemanno F, Houdayer E, Parma A, et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. PLoS One. 2021;16(2):e0246590. https://doi.org/10.1371/journal.pone.0246590
  28. Crivelli L, Calandri I, Corvalán N, et al. Cognitive consequences of COVID-19: results of a cohort study from South America. Arquivos de neuro-psiquiatria. 2022;80(3):240-247.  https://doi.org/10.1590/0004-282X-ANP-2021-0320
  29. Jacob L, Koyanagi A, Smith L, et al. No significant association between COVID-19 diagnosis and the incidence of depression and anxiety disorder? A retrospective cohort study conducted in Germany. Journal of Psychiatric Research. 2022;147:79-84.  https://doi.org/10.1016/j.jpsychires.2022.01.013
  30. Arica-Polat BS, Gündoğdu AA, Cinar N, et al. Evaluation of cognitive deficits in patients infected with COVID-19. European Review for Medical and Pharmacological Sciences. 2022;26(2):678-685.  https://doi.org/10.26355/eurrev_202201_27894
  31. Costas-Carrera A, Sánchez-Rodríguez MM, Cañizares S, et al. Neuropsychological functioning in post-ICU patients after severe COVID-19 infection: The role of cognitive reserve. Brain, Behavior, and Immunity — Health. 2022;21:100425. https://doi.org/10.1016/j.bbih.2022.100425
  32. Matos AMB, Dahy FE, de Moura JVL, et al. Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series. Frontiers in Neurology. 2021;(4)12:678924. https://doi.org/10.3389/fneur.2021.678924
  33. Biagianti B, Di Liberto A, Edoardo AN, et al. Cognitive Assessment in SARS-CoV-2 Patients: A Systematic Review. Frontiers in Aging Neuroscience. 2022(1);14:909661. https://doi.org/10.3389/fnagi.2022.909661
  34. Martínez-Mármol R, Giordano-Santini R, Kaulich E, et al. SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity. Science Advances. 2023;9(23):eadg2248  https://doi.org/10.1126/sciadv.adg2248
  35. Tan BKJ, Han R, Zhao JJ, et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. https://doi.org/10.1136/bmj-2021-069503
  36. Fragiel M, Miró Ò, Llorens P, et al. Incidence, clinical characteristics, risk factors and outcomes of Guillain-Barré syndrome in patients with Covid-19. Annals of Neurology. 2021;89(3):598-603.  https://doi.org/10.1002/ana.25987
  37. Oaklander AL, Mills AJ, Kelley M, et al. Peripheral Neuropathy Evaluations of Patients with Prolonged Long COVID. Neurology(R) Neuroimmunology and Neuroinflammation. 2022;9(3):e1146. https://doi.org/10.1212/NXI.0000000000001146
  38. Michaelson NM, Malhotra A, Wang Z, et al. Peripheral neurological complications during COVID-19: A single center experience. Journal of the Neurological Sciences. 2022;434:120118. https://doi.org/10.1016/j.jns.2021.120118
  39. Saif DS, Ibrahem RA, Eltabl MA. Prevalence of peripheral neuropathy and myopathy in patients post-COVID-19 infection. International Journal of Rheumatic Diseases. 2022;25(11):1246-1253. https://doi.org/10.1111/1756-185X.14409
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.